Mr. Hurtado is an Analyst at the Johns Hopkins Center for Health Security. His primary research interests include pathogen-host interactions, cell signaling, tumor microenvironment, use of nanomedicine for targeted drug delivery, pandemic and emerging infectious disease, public health preparedness and policy, and international collaboration for responses to biosecurity threats.
Mr. Hurtado has a BS in neuroscience from Johns Hopkins University, with a concentration in systems neuroscience. In 2017, he earned an MHS degree from the Department of Biochemistry and Molecular Biology at the Johns Hopkins Bloomberg School of Public Health, concentrating in reproductive and cancer biology. His thesis focused on the differential roles of the various IL-17 cytokine members in colorectal cancer tumorigenesis and progression.
During his time at JHSPH, he worked as a research assistant at the Wilmer Eye Institute, investigating the neuro-immune interactions that regulate retinal regeneration. Additionally, he assisted in the development and implementation of novel assays and transgenic toolsets to perform an in vivo drug discovery test for potential treatments of various retinal diseases. At the Johns Hopkins Neurosurgical clinic, he has analyzed patient records and compiled data for a publication on the safety concerns of endovascular treatment of cerebral aneurysms in patients with fibromuscular dysplasia.